Biotech veteran Una Ryan has joined the nonprofit firm Diagnostics for All as CEO, The Boston Globe reports. Ryan, who is leaving her post as chief executive at Boston University spin-out Waltham Technologies, is also the former CEO of Needham, MA-based Avant Immunotherapeutics (now Celldex Therapeutics). She tells the Globe that one of her plans for Diagnostics for All, which develops paper-based diagnostics for the developing world based on technology from the Harvard lab of chemist George Whitesides, is to start a for-profit company to market the nonprofit group’s tests in the developed world.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
